Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1997
RATIONALE: Some drugs used in chemotherapy can reduce the pain experienced by some people with cancer. Combining more than one drug may be more effective at reducing cancer pain. It is not known whether receiving combination chemotherapy with clodronate is more effective than receiving combination chemotherapy without clodronate for hormone refractory metastatic prostate cancer. PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of combination chemotherapy using mitoxantrone plus prednisone with or without clodronate in treating pain in patients with hormone refractory metastatic prostate cancer.
Epistemonikos ID: 54b9c8c1fc471eb436dacce7d0f5c79d75bd8e00
First added on: May 03, 2024